ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2025 were $2.43, up 29.2% year over year. The metric beat the Zacks Consensus Estimate by 5.6%. The adjustments ...

ResMed outperformed market expectations in Q2, reporting a 10% revenue increase to $US1.3 billion and a 65% surge in net income to $US344.6 million.... "Lorem ipsum ...